Anti-ANGL3/ ANGPTL3/ ANG-5 functional antibody

Anti-ANGL3/ ANGPTL3/ ANG-5 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ANGPTL3/ANGPTL3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T53139-Ab-1/ GM-Tg-hg-T53139-Ab-2Anti-Human ANGPTL3 monoclonal antibodyHuman
GM-Tg-rg-T53139-Ab-1/ GM-Tg-rg-T53139-Ab-2Anti-Rat ANGPTL3 monoclonal antibodyRat
GM-Tg-mg-T53139-Ab-1/ GM-Tg-mg-T53139-Ab-2Anti-Mouse ANGPTL3 monoclonal antibodyMouse
GM-Tg-cynog-T53139-Ab-1/ GM-Tg-cynog-T53139-Ab-2Anti-Cynomolgus/ Rhesus macaque ANGPTL3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T53139-Ab-1/ GM-Tg-felg-T53139-Ab-2Anti-Feline ANGPTL3 monoclonal antibodyFeline
GM-Tg-cang-T53139-Ab-1/ GM-Tg-cang-T53139-Ab-2Anti-Canine ANGPTL3 monoclonal antibodyCanine
GM-Tg-bovg-T53139-Ab-1/ GM-Tg-bovg-T53139-Ab-2Anti-Bovine ANGPTL3 monoclonal antibodyBovine
GM-Tg-equg-T53139-Ab-1/ GM-Tg-equg-T53139-Ab-2Anti-Equine ANGPTL3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T53139-Ab-1/ GM-Tg-hg-T53139-Ab-2; GM-Tg-rg-T53139-Ab-1/ GM-Tg-rg-T53139-Ab-2;
GM-Tg-mg-T53139-Ab-1/ GM-Tg-mg-T53139-Ab-2; GM-Tg-cynog-T53139-Ab-1/ GM-Tg-cynog-T53139-Ab-2;
GM-Tg-felg-T53139-Ab-1/ GM-Tg-felg-T53139-Ab-2; GM-Tg-cang-T53139-Ab-1/ GM-Tg-cang-T53139-Ab-2;
GM-Tg-bovg-T53139-Ab-1/ GM-Tg-bovg-T53139-Ab-2; GM-Tg-equg-T53139-Ab-1/ GM-Tg-equg-T53139-Ab-2
Products NameAnti-ANGPTL3 monoclonal antibody
Formatmab
Target NameANGPTL3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ANGPTL3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-201Pre-Made Evinacumab biosimilar, Whole mAb, Anti-ANGPTL3 Antibody: Anti-ANG-5/ANGPT5/ANL3/FHBL2 therapeutic antibody
    Target AntigenGM-Tg-g-T53139-Ag-1Recombinant multi-species ANGL3/ ANGPTL3/ ANG-5 protein
    ORF Viral VectorvGMLP000724human ANGPTL3 Lentivirus particle
    ORF Viral VectorpGMLP000724human ANGPTL3 Lentivirus plasmid
    ORF Viral VectorpGMLPm001529mouse Angptl3 Lentivirus plasmid
    ORF Viral VectorvGMLPm001529mouse Angptl3 Lentivirus particle


    Target information

    Target IDGM-T53139
    Target NameANGPTL3
    Gene ID27329,30924,502970,695499,102152922,101081151,782603,100054159
    Gene Symbol and SynonymsANG-5,ANGPT5,ANGPTL3,ANL3,FHBL2,hypl
    Uniprot AccessionQ9Y5C1
    Uniprot Entry NameANGL3_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, INN Index
    DiseaseLung Cancer
    Gene EnsemblENSG00000132855
    Target ClassificationN/A

    The target: ANGPTL3, gene name: ANGPTL3, also named as ANG-5, ANGPT5, ANL3, FHBL2. This gene encodes a member of a family of secreted proteins that function in angiogenesis. The encoded protein, which is expressed predominantly in the liver, is further processed into an N-terminal coiled-coil domain-containing chain and a C-terminal fibrinogen chain. The N-terminal chain is important for lipid metabolism, while the C-terminal chain may be involved in angiogenesis. Mutations in this gene cause familial hypobetalipoproteinemia type 2. [provided by RefSeq, Aug 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.